Sivaram Rohan

CFO Sivaram Rohan sold 29,996 shares at $30.67, near 52-week high; 3 of 4 prior CFLT sales were well-timed

Sivaram Rohan, CFO of Confluent, Inc., sold 29,996 shares on 2026-03-12 at $30.67, reducing his holdings by 5.3% to 531,971 shares. The sale occurred at a price only -0.4% below the 52-week high of $30.79, suggesting timing near a peak. His prior trade history at Confluent shows a pattern of discipline: 3 of 4 prior measurable sales resulted in the stock declining within 90 days, indicating well-timed exits. However, the company remains unprofitable with a net income of $-66,504,000.00 in the latest quarter, despite revenue growth of 21.1% year-over-year. The convergence of near-peak pricing with a demonstrated ability to exit ahead of declines warrants monitoring, particularly given the company's profitability challenges.

CFO Sivaram Rohan sells 21,503 shares of CFLT at $30.70; stock now at $30.62. 4 of 5 prior CFLT sales were well-timed.

Sivaram Rohan, CFO of Confluent, sold 21,503 shares at $30.70 on 2026-02-20, reducing his holdings by -3.7% to 562.0K shares. At his prior five CFLT sales, he demonstrated a 80% well-timed rate at the 90-day mark (4 of 5 sells preceded declines), suggesting consistency in sale execution at this company. The current stock price of $30.62 is -7.8% from the 52-week high of $33.23, and the 90-day return since this sale is +40.3%, indicating the stock has risen sharply post-transaction. Confluent remains unprofitable (net income $-66.5M in the latest quarter) despite revenue growth of +21.1% year-over-year, which creates a backdrop of execution risk even as the recent momentum has been positive.

CFO Sivaram Rohan sold 25,858 shares of CFLT at $22.51 on 2025-11-20; stock now at $21.06, -44.1% from 52-week high.

Sivaram Rohan, Chief Financial Officer, sold 25,858 shares for $582,063.58 at $22.51 per share while holding 599,738 shares post-transaction. The sale occurred when CFLT was trading $1.45 above its current price of $21.06, and the stock has since fallen 7.6% over 30 days. Rohan's cross-ticker sell track record shows a 90-day well-timed rate of 83.33%, with his 6 prior sells averaging -21.0% 90-day returns; however, at CFLT specifically, his prior 5 trades show mixed timing, with 4 of 5 well-timed at the 90-day mark. The company reported negative net income of $-66,504,000.00 in the latest quarter despite 24.0% annual revenue growth, indicating operational losses despite topline expansion, a dynamic that may explain the insider activity in the context of execution-stage cash burn.

CFO Sivaram Rohan sold 27.7K shares of CFLT at $21.83; 80% of his prior 5 sells were well-timed, but stock now -41.9% from highs and unprofitable.

Sivaram Rohan, the CFO of Confluent, sold 27,710 shares at $21.83 on 2025-05-20, reducing his holdings by -4.0% to 673,693 shares. His cross-ticker track record shows a 80.00% well-timed rate on 5 prior sells (average 90d return -21.6%), and at CFLT specifically, 4 of 5 prior sells were well-timed at the 90-day mark, suggesting a pattern of selling into or ahead of downturns. However, this sale occurs as CFLT trades -41.9% from its 52-week high of $37.65 and amid persistent unprofitability (net income $-67.6M on revenue $271.1M last quarter), with annual revenue growth still positive at +24.0%. The timing pattern merit attention: the CFO's historical accuracy in identifying selling windows combined with the stock's current distance from peak valuations and the company's ongoing losses creates a signal worth tracking for signs of insider concern about near-term momentum or valuation sustainability.

CFO Rohan sold 23.6K CFLT shares at $31.58 on 2025-02-21; stock now $30.44, -19.2% from 52-week high.

Sivaram Rohan, the CFO, sold 23,605 shares at $31.58 on 2025-02-21, reducing his stake by 4.5% to 497,806 shares. The sale price was slightly above current levels ($30.44) but reflects a stock trading 19.2% below its 52-week high of $37.65, suggesting the transaction occurred as momentum has recently softened. Rohan's cross-ticker track record shows 4 prior sells with an average 90-day return of -3.7% and a 50.00% well-timed rate, indicating mixed execution historically. At CFLT specifically, his prior 2 measurable sales (2024-11-20 and 2024-05-20) had divergent outcomes: the November sale proved well-timed with a +6.2% 30-day return and +23.8% 90-day return, while the May sale was poorly timed with a -12.9% 30-day return and -31.2% 90-day return. The company remains unprofitable with a negative full-year net income of $-74,144,000.00 despite 24.0% annual revenue growth, which adds fundamental headwinds to monitor alongside the transaction.

CFO Sivaram Rohan sells 68,350 shares for $2,476,193.10; holds 520,273 post-transaction as CFLT stock trades near 52-week highs.

Sivaram Rohan, CFO of Confluent, executed 2 separate sales totaling 68,350 shares for $2,476,193.10 at a blended average price of $36.23 on 2025-02-13. This represents an 11.6% reduction in his post-transaction holdings to 520,273 shares. The sales occurred near the stock's 52-week high of $37.65, with the current price at $34.94. Notably, the stock has appreciated 30.9% over 30 days and 22.3% over 90 days, a strong recent rally. The company remains unprofitable on a full-year basis with net income of $-74,144,000, though annual revenue growth stands at 24.0%. His prior trades at CFLT show mixed timing outcomes: a November 2024 sale preceded a 23.8% 90-day gain, while a May 2024 sale preceded a 31.2% decline. The current timing—selling near 52-week highs into sustained upward momentum—contrasts with the May 2024 pattern of selling ahead of declines, but aligns with the recent rally context.

CFLT CFO Rohan sells 22.7K shares at $28.23; now at $31.52, stock +48.1% in 30d.

Sivaram Rohan, CFLT's Chief Financial Officer, sold 22,714 shares on 2024-11-20 at $28.23, reducing his holdings by 4.1% from 555,337 to 532,623 shares. The sale occurred when the stock was trading 8.7% below its 52-week high, and the stock has since rallied strongly, up 48.1% over the prior 30 days. In his prior trade at Confluent (a May 2024 sale), the stock declined 31.2% within 90 days—a well-timed exit—suggesting a pattern of selling ahead of weakness. However, this specific trade occurred as CFLT has entered a strong upward momentum phase, and company fundamentals remain challenged: full-year net income was negative, though annual revenue growth was robust at 32.6%. The combination of CFO selling into upward momentum, paired with unprofitable operations, merits attention to whether this reflects confidence constraints or liquidity needs rather than market timing conviction.